A detailed history of Creative Financial Designs Inc transactions in Novo Nordisk A S stock. As of the latest transaction made, Creative Financial Designs Inc holds 7,509 shares of NVO stock, worth $840,857. This represents 0.08% of its overall portfolio holdings.

Number of Shares
7,509
Previous 8,826 14.92%
Holding current value
$840,857
Previous $1.26 Million 28.99%
% of portfolio
0.08%
Previous 0.11%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 28, 2024

SELL
$119.07 - $145.42 $156,815 - $191,518
-1,317 Reduced 14.92%
7,509 $894,000
Q2 2024

Aug 06, 2024

BUY
$122.71 - $146.91 $3,681 - $4,407
30 Added 0.34%
8,826 $1.26 Million
Q1 2024

May 01, 2024

BUY
$102.11 - $135.92 $85,976 - $114,444
842 Added 10.59%
8,796 $1.13 Million
Q4 2023

Jan 10, 2024

BUY
$87.78 - $105.45 $314,427 - $377,721
3,582 Added 81.93%
7,954 $822,000
Q3 2023

Nov 14, 2023

BUY
$90.94 - $199.54 $332,112 - $728,720
3,652 Added 507.22%
4,372 $397,000
Q2 2023

Jul 26, 2023

BUY
$155.98 - $172.65 $105,286 - $116,538
675 Added 1500.0%
720 $116,000
Q4 2021

Jan 26, 2022

SELL
$95.88 - $117.08 $11,793 - $14,400
-123 Reduced 73.21%
45 $5,000
Q3 2021

Oct 08, 2021

BUY
$84.42 - $106.62 $84 - $106
1 Added 0.6%
168 $16,000
Q2 2020

Jul 23, 2020

BUY
$58.54 - $67.94 $9,776 - $11,345
167 New
167 $11,000
Q1 2019

Apr 23, 2019

SELL
$46.36 - $52.63 $2,225 - $2,526
-48 Closed
0 $0
Q4 2018

Jan 24, 2019

SELL
$41.54 - $47.25 $5,690 - $6,473
-137 Reduced 74.05%
48 $2,000
Q3 2018

Nov 02, 2018

SELL
$46.76 - $51.24 $8,183 - $8,967
-175 Reduced 48.61%
185 $9,000
Q2 2018

Jul 13, 2018

BUY
$44.29 - $50.42 $13,951 - $15,882
315 Added 700.0%
360 $17,000
Q4 2016

Mar 14, 2018

BUY
N/A
45
45 $2,000

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $253B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Creative Financial Designs Inc Portfolio

Follow Creative Financial Designs Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Creative Financial Designs Inc , based on Form 13F filings with the SEC.

News

Stay updated on Creative Financial Designs Inc with notifications on news.